AmbioGen AB

ABActive

Org 5594534157Visionsgatan 56, 171 64 SolnaResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2023 · 2 years old4 employees

Overview Financials People & ownership Related companies

AmbioGen AB is a Swedish AB based in Solna, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2023, the company has 4 employees and reported revenue of SEK 4,8M in its latest annual filing.

Revenue 2025

SEK 4,8M

+102% vs 2024

EBITDA margin

35.7%

+39% vs 2024

Net profit 2025

SEK 1,4M

+39% vs 2024

Key ratios

See full ratios →

74.5%

This company

20242025

3.9×

This company

20242025

42.9%

This company

20242025

EBITDA — year on year

SEK millions

Key figures

Annual report 2025

Revenue	SEK 4,8M	+102%
EBITDA	SEK 1,7M	+39%
Net profit	SEK 1,4M	+39%
Total assets	SEK 3,2M	+9%
Equity	SEK 2,4M	+136%
Employees	4	—

Contact

Address

Visionsgatan 56, 171 64 Solna

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of AmbioGen AB?

AmbioGen AB is registered with Bolagsverket / SCB under Org 5594534157.

What is the revenue of AmbioGen AB?

AmbioGen AB reported revenue of SEK 4,8M in 2025.

How many employees does AmbioGen AB have?

AmbioGen AB employs 4 people as of the latest annual report.

Who is the CEO of AmbioGen AB?

Maike Seifert is the CEO of AmbioGen AB.

Where is AmbioGen AB headquartered?

AmbioGen AB's registered address is Visionsgatan 56.

AmbioGen AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on AmbioGen AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on AmbioGen AB